Company research / OTLK
Outlook Therapeutics, Inc. (OTLK)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Sep 30
For the year ended 2025-09-30, Outlook Therapeutics, Inc. reported revenue of $1.41M.
Key ratios (year ended 2025-09-30)
4.0%
Gross margin
-4744.3%
Operating margin
-4416.2%
Net margin
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.